This company listing is no longer active
Osmozis Balance Sheet Health
Financial Health criteria checks 6/6
Osmozis has a total shareholder equity of €15.7M and total debt of €14.1M, which brings its debt-to-equity ratio to 90%. Its total assets and total liabilities are €34.0M and €18.3M respectively. Osmozis's EBIT is €1.6M making its interest coverage ratio 4.4. It has cash and short-term investments of €10.6M.
Key information
90.0%
Debt to equity ratio
€14.11m
Debt
| Interest coverage ratio | 4.4x |
| Cash | €10.64m |
| Equity | €15.68m |
| Total liabilities | €18.35m |
| Total assets | €34.03m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 9VL's short term assets (€16.5M) exceed its short term liabilities (€6.3M).
Long Term Liabilities: 9VL's short term assets (€16.5M) exceed its long term liabilities (€12.1M).
Debt to Equity History and Analysis
Debt Level: 9VL's net debt to equity ratio (22.1%) is considered satisfactory.
Reducing Debt: 9VL's debt to equity ratio has reduced from 117.4% to 90% over the past 5 years.
Debt Coverage: 9VL's debt is well covered by operating cash flow (28.5%).
Interest Coverage: 9VL's interest payments on its debt are well covered by EBIT (4.4x coverage).